B-Cell Targeted Desensitization With Carfilzomib for Preformed Anti-HLA Antibodies in Patients Awaiting Kidney Transplantation
Phase of Trial: Phase I
Latest Information Update: 05 Aug 2017
At a glance
- Drugs Carfilzomib (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 28 Jul 2017 Number of arms changed from 1 to 4,hence patient number also changed from 8 to 32.
- 24 Jul 2017 Planned number of patients changed from 8 to 32.
- 24 Jul 2017 Planned End Date changed from 1 Jan 2017 to 1 Apr 2018.